TNGNQ — Tengion Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.00m
- $28.39m
Annual income statement for Tengion, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
C2009 December 31st | 2010 December 31st | 2011 December 31st | C2012 December 31st | 2013 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 28.4 | 23.7 | 32.7 | 16.2 | 16.6 |
| Operating Profit | -28.4 | -23.7 | -32.7 | -16.2 | -16.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -29.8 | -25.6 | -19.1 | -16.9 | -18.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -29.8 | -25.6 | -19.1 | -16.9 | -18.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -29.8 | -25.6 | -19.1 | -16.9 | -18.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Dilution Adjustment | |||||
| Diluted Net Income | -43.9 | -29.6 | -19.1 | -16.9 | -18.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -617 | -32.2 | -4.61 | -7.13 | -4.7 |
| Dividends per Share |